Cargando…
Effect of Oral Docosahexaenoic Acid (DHA) Supplementation on DHA Levels and Omega-3 Index in Red Blood Cell Membranes of Breast Cancer Patients
Rationale: Docosahexaenoic acid (DHA) in cell membrane may influence breast cancer (BC) patients' prognosis, affecting tumor cells sensitivity to chemo- and radio-therapy and likely modulating inflammation. The possibility of identifying BC patients presenting with low DHA levels and/or low abi...
Autores principales: | Molfino, Alessio, Amabile, Maria I., Mazzucco, Sara, Biolo, Gianni, Farcomeni, Alessio, Ramaccini, Cesarina, Antonaroli, Simonetta, Monti, Massimo, Muscaritoli, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532437/ https://www.ncbi.nlm.nih.gov/pubmed/28804463 http://dx.doi.org/10.3389/fphys.2017.00549 |
Ejemplares similares
-
DHA Oral Supplementation Modulates Serum Epoxydocosapentaenoic Acid (EDP) Levels in Breast Cancer Patients
por: Molfino, Alessio, et al.
Publicado: (2019) -
The Role of Docosahexaenoic Acid (DHA) in the Control of Obesity and Metabolic Derangements in Breast Cancer
por: Molfino, Alessio, et al.
Publicado: (2016) -
Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both?
por: Molfino, Alessio, et al.
Publicado: (2017) -
The Role for Dietary Omega-3 Fatty Acids Supplementation in Older Adults
por: Molfino, Alessio, et al.
Publicado: (2014) -
Prenatal choline supplementation improves biomarkers of maternal docosahexaenoic acid (DHA) status among pregnant participants consuming supplemental DHA: a randomized controlled trial
por: Klatt, Kevin C, et al.
Publicado: (2022)